ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Patient-Centric Formulations In Pediatric Adherence

  Improving pediatric adherence requires age-appropriate formulations, taste-masking, and swallowability strategies. Regulatory, clinical, and technological insights help overcome barriers and support safer, more effective therapies for children across developmental stages.

• The Road To Agile Pharmaceutical Manufacturing

  Battelle helped a specialty pharma company pioneer in-package 3D printing for personalized meds—demonstrating how agile manufacturing transforms pharma production from concept to capability.

• Maintaining Drug Bioavailability And Masking Taste With Microencapsulation

  Several technologies are available for microencapsulating drugs. Finding the right CDMO to optimize a drug’s efficacy and manufacturing during formulation is integral to its clinical and commercial success.

• Compliance Considerations For Emergency-Use Delivery Systems

  Because auto-injectors are typically the delivery device of choice for emergency medications, they come with increased scrutiny from regulatory bodies regarding their safety and effectiveness.

• Trends In Drug Delivery: The Growth Of Cartridge Based Technology

  As pharma companies evaluate the delivery systems for their drug product, there are several reasons why they may select a cartridge-based system compared to a pre-filled syringe or vial. 

• FAQs On The Revised EU GMP Annex 1: Volume 2

  Review the implementation of a holistic Contamination Control Strategy (CCS). Discover four key considerations for assessing component readiness: product, process, protection, and proof.

• Application Of A Novel Temperature Shift Process For Particle Engineering

  Spray drying of amorphous dispersions improves solubility and bioavailability, enabling supersaturation in the intestine and driving higher absorption rates when compared to crystalline drug forms.

• Designing Delivery Devices For Older Adults With Cognitive Impairment

  Leverage our insights to improve your human factors studies and ensure the effective inclusion of older adults with mild cognitive impairment.

• Viral Vector Based Gene Therapy Drug Products: The Right Primary Container

  Explore the major considerations for an ideal primary container for viral vector-based gene therapy drug products and the existing and new solutions in this space.

• Nanoparticle Engineering Addresses The Challenge Of Poor Aqueous Solubility

  As pharma companies aim to overcome development obstacles, it is important to incorporate GMP expertise alongside novel technologies that can enhance the properties of APIs and dosage forms.